DIABLO and cancer: As SMAC is known to form homodimers when binding to IAPs, both monovalent (e.g., LCL161) and bivalent (e.g., BV6 and Birinapant) SMAC mimetics have been developed, with the bivalent compounds showing higher binding affinity and correspondingly higher potency and anti-cancer activity.